Outcomes of lung transplant candidates referred for co-management by palliative care: A retrospective case series

Palliative Medicine

Volumn 29, Issue 5, 2015, Pages 429-435

  Colman, Rebecca ^a   Singer, Lianne G ^a,b   Barua, Reeta ^c   Downar, James ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

analgesics; chronic obstructive; cystic fibrosis; hypertension; interstitial; lung diseases; opioid; Organ transplantation; palliative care; pulmonary; pulmonary disease

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CONSULTATION; DISEASE COURSE; DYSPNEA; EXERCISE; FEMALE; FOLLOW UP; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PATIENT REFERRAL; PRESCRIPTION; TREATMENT OUTCOME; AGED; COMPLICATION; DISEASE MANAGEMENT; EPIDEMIOLOGY; HOSPITAL MORTALITY; LUNG DISEASES; MIDDLE AGED; MORTALITY; ONTARIO; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ANALGESICS, OPIOID; DISEASE MANAGEMENT; DYSPNEA; FEMALE; HOSPITAL MORTALITY; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; ONTARIO; PALLIATIVE CARE; RETROSPECTIVE STUDIES;

EID: 84929174255     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216314566839     Document Type: Article

References (37)

1. Robinson W. Palliative and end-of-life care in cystic fibrosis: what we know and what we need to know. Curr Opin Pulm Med. 2009; 15 (6). 621-625
2. Vermeulen KM, Groen H, van der Bij W, et al. The effect of bronchiolitis obliterans syndrome on health related quality of life. Clin Transplant. 2004; 18 (4). 377-383
3. Fusar-Poli P, Lazzaretti M, Ceruti M, et al. Depression after lung transplantation: causes and treatment. Lung. 2007; 185 (2). 55-65
4. WHO. WHO definition of palliative care, http://www.who.int/cancer/palliative/definition/en/(2012, accessed 16 December 2012).
5. Selecky PA, Eliasson CA, Hall RI, et al. Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest. 2005; 128 (5). 3599-3610
6. Lanken PN, Terry PB, Delisser HM, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008; 177 (8). 912-927
7. Marciniuk DD, Goodridge D, Hernandez P, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011; 18 (2). 69-78
8. Mahler DA, Selecky PA, Harrod CG, et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010; 137 (3). 674-691
9. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. National Institute for Health and Care Excellence (NICE), https://www.nice.org.uk/guidance/cg101 (accessed 12 November 2014).
10. Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage. 2011; 42 (3). 388-399
11. Rocker G, Simpson C, Young J, et al. Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients' experiences and outcomes. CMAJ Open. 2013; 1: E27-E36
12. Song M-K, De Vito Dabbs A, Studer SM, et al. Palliative care referrals after lung transplantation in major transplant centers in the United States. Crit Care Med. 2009; 37 (4). 1288-1292
13. Colman RE, Curtis JR, Nelson JE, et al. Barriers to optimal palliative care of lung transplant candidates. Chest. 2013; 143 (3). 736-743
14. Rocker G, Young J, Donahue M, et al. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease. CMAJ. 2012; 184 (9). E497-E504
15. Partridge MR, Khatri A, Sutton L, et al. Palliative care services for those with chronic lung disease. Chron Respir Dis. 2009; 6 (1). 13-17
16. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012; 185 (4). 435-452
17. Janssen DJ, Spruit MA, Does JD, et al. End-of-life care in a COPD patient awaiting lung transplantation: a case report. BMC Palliat Care. 2010; 9: 6
18. Ferrin M, Happ MB, Kagan SH. Palliative care and lung transplantation: conflict or continuum?. Am J Nurs. 2001; 101 (2). 61-66
19. Song MK, De Vito Dabbs A, Studer SM, et al. Course of illness after the onset of chronic rejection in lung transplant recipients. Am J Crit Care. 2008; 17 (3). 246-253
20. Lindell KO, Liang Z, Hoffman LA, et al. Palliative care and location of death in decedents with idiopathic pulmonary fibrosis. Chest. 2014;:
21. Bruera E, Kuehn N, Miller MJ, et al. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991; 7 (2). 6-9
22. Anderson F, Downing GM, Hill J, et al. Palliative Performance Scale (PPS): a new tool. J Palliat Care. 1996; 12 (1). 5-11
23. ACSM's guidelines for exercise testing and prescription. 8 th ed.Philadelphia, PA: Lippincott Williams & Wilkins, 2009. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:
24. Braithwaite M, Philip J, Tranberg H, et al. End of life care in CF: patients, families and staff experiences and unmet needs. J Cyst Fibros. 2011; 10 (4). 253-257
25. Molmenti EP, Dunn GP. Transplantation and palliative care: the convergence of two seemingly opposite realities. Surg Clin North Am. 2005; 85 (2). 373-382
26. Estfan B, Mahmoud F, Shaheen P, et al. Respiratory function during parenteral opioid titration for cancer pain. Palliat Med. 2007; 21 (2). 81-86
27. Clemens KE, Klaschik E. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage. 2007; 33 (4). 473-481
28. Clemens KE, Klaschik E. Effect of hydromorphone on ventilation in palliative care patients with dyspnea. Support Care Cancer. 2008; 16 (1). 93-99
29. Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008; 300 (14). 1665-1673
30. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010; 363 (8). 733-742
31. Quill TE. Perspectives on care at the close of life. Initiating end-of-life discussions with seriously ill patients: addressing the "elephant in the room.". JAMA. 2000; 284 (19). 2502-2507
32. Fan E, Pham T. Extracorporeal membrane oxygenation for severe acute respiratory failure: yes we can! (But should we?). Am J Respir Crit Care Med. 2014; 189 (11). 1293-1295
33. Stephens RS, Fan E. Choosing wisely-when to mend a broken heart with ECMO?. Crit Care. 2014; 18 (1). 112
34. Swetz KM, Freeman MR, AbouEzzeddine OF, et al. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc. 2011; 86 (6). 493-500
35. Swetz KM, Kamal AH, Matlock DD, et al. Preparedness planning before mechanical circulatory support: a "how-to" guide for palliative medicine clinicians. J Pain Symptom Manage. 2014; 47 (5). 926-935
36. Jennings AnneLDavies AndrewNHiggins JulianPT. Opioids for the palliation of breathlessness in advanced disease and terminal illness. Cochrane Database Syst Rev2012; 7, http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002066.pub2/abstract
37. Hertz MI. The registry of the International Society for Heart and Lung Transplantation-introduction to the 2012 annual reports: new leadership, same vision. J Heart Lung Transplant. 2012; 31 (10). 1045-1051